Santaris Pharma Begins Human Clinical Testing of the World’s First Medicine Targeted at a Human microRNA

News   May 28, 2008

 
Santaris Pharma Begins Human Clinical Testing of the World’s First Medicine Targeted at a Human microRNA
 
 
 

RELATED ARTICLES

RNAi-based Drug Shows Promise as Treatment for Chronic Hepatitis B

News

The novel therapy by Arrowhead Pharmaceuticals uses a mechanism called RNA interference to reduce the surface antigens created by chronic HBV infections.

READ MORE

A More Effective Alternative to RNAi, CRISPR for Studying Protein Function

News

Trim-Away is a novel method enabling researchers to directly and rapidly destroy any protein in any kind of cell.

READ MORE

Vaccine Against Diabetes Closer Than Ever

News

Scientists at the University of Tampere (Finland) and the Karolinska Institutet (Sweden) have demonstrated that an enterovirus vaccine can protect against virus-induced diabetes in a mouse model for Type 1 diabetes.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE